Literature DB >> 7930358

Blood pressure measurement by eye care practitioners.

M G Harris1, C M Gan, E J Revelli, C Imamura, B Kinoshita.   

Abstract

We surveyed a random sample of 250 optometrists (OD) and 250 ophthalmologists (MD) in November 1991 to determine if they were involved in blood pressure measurement. A 50.4 percent and 34.8 percent response rate was obtained from ODs and MDs, respectively. Of those responding, 85 percent of the optometrists and 87 percent of the ophthalmologists reported that they did routinely question their patients about blood pressure, while 65.9 percent of the optometrists and 94.2 percent of the ophthalmologists reported owning blood pressure measurement equipment. Of those owning blood-pressure measuring equipment, approximately 20 percent of both professions reported measuring blood pressure on patients with a defined set of historical or observed risk factors. More optometrists should own blood pressure measurement equipment and measure blood pressure on a routine basis. The detection, referral, and co-management of hypertension by optometrists is important in providing primary health care.

Entities:  

Mesh:

Year:  1994        PMID: 7930358

Source DB:  PubMed          Journal:  J Am Optom Assoc        ISSN: 0003-0244


  3 in total

Review 1.  Hypertension and the eye.

Authors:  James S Wolffsohn; Peter G Hurcomb
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Effectiveness of in-office blood pressure measurement by eye care practitioners in early detection and management of hypertension.

Authors:  Saud A AlAnazi; Uchechukwu L Osuagwu; Turki M AlMubrad; Hany K Ahmed; Kelechi C Ogbuehi
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

3.  Screening for High Blood Pressure in Adults During Ambulatory Nonprimary Care Visits: Opportunities to Improve Hypertension Recognition.

Authors:  Joel Handler; Yasmina Mohan; Michael H Kanter; Kristi Reynolds; Xia Li; Miki Nguyen; Deborah R Young; Corinna Koebnick
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-13       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.